irasia.com - Investor Relations Asia Pacific
HOME

CSPC Pharmaceutical Group Limited
(Formerly known as China Pharmaceutical Group Limited)
(Incorporated in Hong Kong under the Companies Ordinance)

Announcements & Notices       


Please download the latest "Acrobat Reader" to view the PDF.

  • 2021-December-29
  • VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE PRMT5 INHIBITOR "SYHX2001" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
  • 2021-December-29
  • SUPPLEMENTAL ANNOUNCEMENT RELATING TO THE RENEWED LEASE AGREEMENTS (in PDF)
  • 2021-December-22
  • CONNECTED TRANSACTIONS - RENEWAL OF LEASE AGREEMENTS (in PDF)
  • 2021-December-22
  • CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF MASTER PURCHASE AGREEMENT (in PDF)
  • 2021-December-14
  • VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE 1/2 CLINICAL TRIAL OF JMT601 IN THE U.S. (in PDF)
  • 2021-December-3
  • VOLUNTARY ANNOUNCEMENT - INCLUSION OF ANFULIKE IN THE NATIONAL REIMBURSEMENT DRUG LIST (in PDF)
  • 2021-November-22
  • CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF MASTER SALES AGREEMENT (in PDF)
  • 2021-November-22
  • VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH KEYMED BIOSCIENCE (CHENGDU) CO., LTD. FOR CM326 (in PDF)
  • 2021-November-18
  • QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2021 (in PDF)
  • 2021-November-8
  • DATE OF BOARD MEETING (in PDF)
  • 2021-October-21
  • INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THIRD QUARTER OF 2021 (in PDF)
  • 2021-October-21
  • REVISION OF ANNUAL CAP FOR CONTINUING CONNECTED TRANSACTIONS (in PDF)
  • 2021-October-15
  • VOLUNTARY ANNOUNCEMENT - "APIXABAN TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2021-September-30
  • REVISION OF ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS (in PDF)
  • 2021-September-23
  • VOLUNTARY ANNOUNCEMENT - STRATEGIC ALLIANCE AGREEMENT WITH KEYMED BIOSCIENCE (CHENGDU) CO., LTD (in PDF)
  • 2021-September-2
  • VOLUNTARY ANNOUNCEMENT - NBL-015 OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
  • 2021-September-1
  • VOLUNTARY ANNOUNCEMENT - "OSELTAMIVIR PHOSPHATE CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2021-August-26
  • 2021 INTERIM DIVIDEND (in PDF)
  • 2021-August-26
  • 2021 INTERIM RESULTS ANNOUNCEMENT (in PDF)
  • 2021-August-23
  • VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH JIANGSU ALPHAMAB FOR THE DEVELOPMENT AND COMMERCIALIZATION OF KN026 IN CHINA (in PDF)
  • 2021-August-19
  • INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE HALF YEAR ENDED 30 JUNE 2021 (in PDF)
  • 2021-August-17
  • VOLUNTARY ANNOUNCEMENT - STRATEGIC PARTNERSHIP AND LICENSE AGREEMENT WITH FLAME BIOSCIENCES (in PDF)
  • 2021-August-16
  • DATE OF BOARD MEETING (in PDF)
  • 2021-August-9
  • VOLUNTARY ANNOUNCEMENT - "AFATINIB DIMALEATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2021-July-16
  • VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE "SYSA1801" OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (in PDF)
  • 2021-June-25
  • VOLUNTARY ANNOUNCEMENT - "TOFACITINIB CITRATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2021-June-16
  • VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE "SYSA1801" OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
  • 2021-June-9
  • VOLUNTARY ANNOUNCEMENT - ANTI-TUMOR NANODRUG "SIROLIMUS FOR INJECTION (ALBUMIN-BOUND)" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
  • 2021-June-8
  • VOLUNTARY ANNOUNCEMENT - "PREGABALIN CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2021-May-31
  • VOLUNTARY ANNOUNCEMENT - "LACOSAMIDE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2021-May-25
  • VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE CDK9 INHIBITOR "SYHX1903" OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
  • 2021-May-25
  • VOLUNTARY ANNOUNCEMENT - "LINAGLIPTIN TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2021-May-25
  • VOLUNTARY ANNOUNCEMENT - NBL-015 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (in PDF)
  • 2021-May-24
  • QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2021 (in PDF)
  • 2021-May-20
  • VOLUNTARY ANNOUNCEMENT - INNOVATIVE DRUG "SYHA1811 TABLETS" OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
  • 2021-May-18
  • POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 18 MAY 2021 (in PDF)
  • 2021-May-11
  • DATE OF BOARD MEETING (in PDF)
  • 2021-May-11
  • VOLUNTARY ANNOUNCEMENT - "SITAGLIPTIN PHOSPHATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2021-May-11
  • VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION" (in PDF)
  • 2021-May-11
  • VOLUNTARY ANNOUNCEMENT - "SORAFENIB TOSYLATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2021-May-11
  • VOLUNTARY ANNOUNCEMENT - "ALOGLIPTIN BENZOATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2021-May-7
  • VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL FIRST-IN-CLASS PRODUCT SYSA1801 GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA (in PDF)
  • 2021-April-30
  • CONNECTED TRANSACTION - DISPOSAL OF 49.5% EQUITY INTEREST IN JOINT VENTURE COMPANY /CONTINUING CONNECTED TRANSACTIONS - MASTER PURCHASE AGREEMENT (in PDF)
  • 2021-April-26
  • INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2021 (in PDF)
  • 2021-April-23
  • VOLUNTARY ANNOUNCEMENT - NBL-012 OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
  • 2021-April-19
  • VOLUNTARY ANNOUNCEMENT - APPLICATION FOR MARKETING APPROVAL OF "DUVELISIB CAPSULES" ACCEPTED BY NMPA (in PDF)
  • 2021-April-14
  • NOTICE OF ANNUAL GENERAL MEETING (in PDF)
  • 2021-April-9
  • INVESTIGATIONAL NEW DRUG NBL-015 GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA (in PDF)
  • 2021-April-1
  • VOLUNTARY ANNOUNCEMENT - "AMPHOTERICIN B CHOLESTERYL SULFATE COMPLEX FOR INJECTION" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2021-March-30
  • VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PHASE I CLINICAL TRIAL OF "DOCETAXEL FOR INJECTION (ALBUMIN-BOUND)" (in PDF)
  • 2021-March-29
  • VOLUNTARY ANNOUNCEMENT - JMT601 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (in PDF)
  • 2021-March-25
  • VOLUNTARY ANNOUNCEMENT - JMT601 OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
  • 2021-March-16
  • VOLUNTARY ANNOUNCEMENT - DUAL INHIBITOR JAK-SyK "SYHX1901" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
  • 2021-March-15
  • ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020 (in PDF)
  • 2021-March-10
  • VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND COMMERCIALIZATION AGREEMENT (in PDF)
  • 2021-March-9
  • VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND COMMERCIALIZATION AGREEMENT (in PDF)
  • 2021-March-9
  • LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
  • 2021-March-5
  • APPOINTMENT AND RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTORS (in PDF)
  • 2021-March-5
  • POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 5 MARCH 2021 (in PDF)
  • 2021-March-4
  • INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 December 2020 (in PDF)
  • 2021-March-3
  • DATE OF BOARD MEETING (in PDF)
  • 2021-February-7
  • NOTICE OF 2021 FIRST EXTRAORDINARY GENERAL MEETING (in PDF)
  • 2021-February-1
  • PROPOSED ISSUE OF RMB SHARES UNDER SPECIFIC MANDATE PROPOSED AMENDMENTS TO ARTICLES OF ASSOCIATION (in PDF)
  • 2021-January-27
  • LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
  • 2021-January-27
  • APPOINTMENT AND RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGE OF BOARD COMMITTEE S (in PDF)
  • 2021-January-8
  • VOLUNTARY ANNOUNCEMENT - NBL-012 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (in PDF)
  • 2022
  • 2022 Announcements & Notices
  • 2020
  • 2020 Announcements & Notices
  • 2019
  • 2019 Announcements & Notices
  • 2018
  • 2018 Announcements & Notices
  • 2017
  • 2017 Announcements & Notices
  • 2016
  • 2016 Announcements & Notices
  • 2015
  • 2015 Announcements & Notices
  • 2014
  • 2014 Announcements & Notices
  • 2013
  • 2013 Announcements & Notices
  • 2012
  • 2012 Announcements & Notices
  • 2011
  • 2011 Announcements & Notices
  • 2010
  • 2010 Announcements & Notices
  • 2009
  • 2009 Announcements & Notices
  • 2008
  • 2008 Announcements & Notices
  • 2007
  • 2007 Announcements & Notices
  • 2006
  • 2006 Announcements & Notices


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Disclaimer
    © Copyright 1996-2022 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.